Zeaxanthin4
Central Macula Protection
- 4 mg of zeaxanthin combined with 25 mg of fat soluble Vitamin C
- Increases central macula protection from UV damage.
- Supports neural tissue and the immune system
- 180 capsule count per bottle
-
Recommended dosage: 1 capsule daily
-
Manufactured in NSF certified facility to FDA Good Manufacturing Practice Standards (GMP) and presented in vegetable capsules for maximum absorption.
-
Sold with full money back guarantee
Zeaxanthin Product Information
Zeaxanthin Overview
Zeaxanthin is suggested in peer-reviewed literature to be the central macula preference over lutein. Dietary and supplemental Zeaxanthin is preferentially deposited at the center of the macula. If the diet is deficient in zeaxanthin, which most diets are, and supplemental zeaxanthin is not available, the macula preference for zeaxanthin is so strong the body will convert a small amount of dietary lutein to a similar molecule called meso-zeaxanthin in an attempt to supply the eye with pigment that best protects the macula. Meso zeaxanthin is not found anywhere in the body, except in the eye.
Scientific Rationale Behind Zeaxanthin
Scientific research has established that dietary zeaxanthin plays an essential role in protecting the retina of the eye from the damaging effects of light.
Beta-carotene has the ability to convert to retinol, if the vitamin A liver stores are deficient, which they are in many older people. Vitamin A deficiency can be responsible for night driving problems in the older population.
Unfortunately, unlike beta-carotene, zeaxanthin and lutein have almost no ability to convert to Vitamin A retinol, so the science behind the substitution is a bit flawed - since Vitamin A retinol is vital to the health of the retina, specifically the rods and cones.
The best solution: supplement with biochemically balanced amounts of zeaxanthin, lutein, and vitamin A as retinyl palmitate, in a full-spectrum supplement. Additional zeaxanthin or lutein supplementation should be the decision of the consumer and his or her eye care professional.
Carotenoid Cation Formation and the Regulation of Photosynthetic Light Harvesting. Holt, N, Zigmantas D, Valkunas L, et al. Science, Vol 307 Issue 5708, 433-436, January 21, 2005 [abstract]
Long term dietary supplementation with zeaxanthin reduces photoreceptor death in light-damaged Japanese quail. Thomson LR, Toyoda Y, et al. Exp Eye Res. 2002 Nov;75(5):529-42. [abstract]
-
QWho holds the patent on zeaxanthin?
Dennis Geirhart, PhD. The US courts ruled that supplement manufacturers can include up to 4 mg of zeaxanthin in a multiple or disease-specific formulation.
-
QWhat is the recommended daily amount for zeaxanthin?
At this point RDA for zeaxanthin has not been established.
-
QShould I take more than the 3 and 4 mgs of zeaxanthin you include in Oculair and Macula Complete?
Dennis Geirhart, PhD, a much admired research scientist and the zeaxanthin patent holder, includes 5 to 20 mg per day in his EyePromise and EyePromise Complete products. It's important to remember that zeaxanthin, unlike beta-carotene, has virtually no ability to convert to Vitamin A retinol, so the eye or macula specific formulations that don't include beta-carotene or Vitamin A, as retinyl palmitate, leave the patient consumer with no supplemental vitamin A, which is particularly necessary for night vision in older people. We recommend that you and your doctor make the decision regarding zeaxanthin supplementation over the 3 and 4 mgs included in Biosyntrx Oculair and Macula Complete.
-
QIs zeaxanthin supplementation safe?
Zeaxanthin has been granted Generally Recognized As Safe (GRAS) status.
-
QWhy should I supplement with zeaxanthin?
Zeaxanthin is a powerful antioxidant, as well as the central macula pigment carotenoid preference for UV protection. However, do remember that macula pigment is just one of the issues in the macular degeneration disease process. Zeaxanthin in-vitro studies, yet to be published in peer-reviewed journal, suggest both vascular endothelial growth factor (VEGF) and nuclear factor kappa beta (NFkB) modulation activity in the diabetic eye. A number of plant-based antioxidants, including grape seed and berry anthocyanidins, have already been suggested in published peer-reviewed science to modulate these gene-based transcription factors associated with diseases of the retina - including macular degeneration.
